Phenomenex, Inc. Release: New Positive Pressure Manifold Streamlines Sample Preparation

Torrance, Calif. (July 14, 2016) – Phenomenex Inc., a global leader in the research, design and manufacture of advanced technologies for the separation sciences, introduces the Presston™ 100 Positive Pressure Manifold for sample preparation. An alternative to the vacuum manifold, Presston 100 applies pressure from above to pass liquids through the sample preparation products. Presston 100 reduces the inconsistent pressures that are inherent in vacuum techniques, and its high-pressure capability enables the separation of viscous samples.

Presston 100 is unique in that a single unit can prepare samples in tubes or 96-well plates. Other manufacturers’ manifolds require a separate unit for each format. Phenomenex offers a simple tube adapter kit for Presston that converts between tubes and 96-well plates.

“Phenomenex offers so many sample preparation solutions that it makes sense to provide a manifold that can process them efficiently,” said Erica Safan, brand manager for Phenomenex. “The ability to handle tubes or plates along with the other advantages of positive pressure allow the user to do more with just one instrument.”

Presston 100 is compatible with Phenomenex Strata® solid phase extraction (SPE), Novum™ simplified liquid extraction (SLE), Phree™ phospholipid removal, Impact™ protein precipitation plates, ß-Gone™ ß-glucuronidase removal and Clarity® synthetic DNA and RNA biosolutions.

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government and academic laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being. For more information on Phenomenex, visit www.phenomenex.com or follow the company on Twitter @Phenomenex.

MORE ON THIS TOPIC